Neuronal Network Oscillations in Neurodegenerative Diseases

被引:0
作者
Volker Nimmrich
Andreas Draguhn
Nikolai Axmacher
机构
[1] AbbVie Deutschland GmbH & Co. KG,Institute of Experimental and Clinical Pharmacology and Toxicology
[2] R & D,Institute for Physiology and Pathophysiology
[3] Medical Faculty Mannheim University of Heidelberg,Department of Neuropsychology, Institute of Cognitive Neuroscience
[4] University of Heidelberg,undefined
[5] Ruhr University Bochum,undefined
[6] German Centre for Neurodegenerative Diseases,undefined
来源
NeuroMolecular Medicine | 2015年 / 17卷
关键词
Oscillations; Alzheimer’s dementia; Biomarker; Neurodegenerative diseases; Parkinson’s disease; EEG;
D O I
暂无
中图分类号
学科分类号
摘要
Cognitive and behavioral acts go along with highly coordinated spatiotemporal activity patterns in neuronal networks. Most of these patterns are synchronized by coherent membrane potential oscillations within and between local networks. By entraining multiple neurons into a common time regime, such network oscillations form a critical interface between cellular activity and large-scale systemic functions. Synaptic integrity is altered in neurodegenerative diseases, and it is likely that this goes along with characteristic changes of coordinated network activity. This notion is supported by EEG recordings from human patients and from different animal models of such disorders. However, our knowledge about the pathophysiology of network oscillations in neurodegenerative diseases is surprisingly incomplete, and increased research efforts are urgently needed. One complicating factor is the pronounced diversity of network oscillations between different brain regions and functional states. Pathological changes must, therefore, be analyzed separately in each condition and affected area. However, cumulative evidence from different diseases may result, in the future, in more unifying “oscillopathy” concepts of neurodegenerative diseases. In this review, we report present evidence for pathological changes of network oscillations in Alzheimer’s disease (AD), one of the most prominent and challenging neurodegenerative disorders. The heterogeneous findings from AD are contrasted to Parkinson’s disease, where motor-related changes in specific frequency bands do already fulfill criteria of a valid biomarker.
引用
收藏
页码:270 / 284
页数:14
相关论文
共 993 条
[11]  
Peña-Ortega F(2009)Assessing neuronal networks: understanding Alzheimer’s disease Progress in Neurobiology 89 125-133
[12]  
Amatniek JC(2009)Cholinergic modulation of MEG resting-state oscillatory activity in Parkinson’s disease related dementia Clinical Neurophysiology 120 910-915
[13]  
Hauser WA(2006)Resting state oscillatory brain dynamics in Parkinson’s disease: An MEG study Clinical Neurophysiology 117 2521-2531
[14]  
DelCastillo-Castaneda C(2002)Amplitude differences of evoked alpha and gamma oscillations in two different age groups International Journal of Psychophysiology 45 245-251
[15]  
Jacobs DM(2005)Basal ganglia local field potential activity: Character and functional significance in the human Clinical Neurophysiology 116 2510-2519
[16]  
Marder K(2012)Critical role of soluble amyloid-β for early hippocampal hyperactivity in a mouse model of Alzheimer’s disease Proceedings of the National Academy of Sciences of the United States of America 109 8740-8745
[17]  
Bell K(2008)Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer’s disease Science 321 1686-1689
[18]  
Albert M(2002)Theta oscillations in the hippocampus Neuron 33 325-340
[19]  
Brandt J(2004)Neuronal oscillations in cortical networks Science 304 1926-1929
[20]  
Stern Y(1989)The cholinergic nucleus basalis: A key structure in neocortical arousal EXS 57 159-171